Strong CAG Sales to Aid IDEXX Laboratories' (IDXX) Q2 Earnings

IDEXX Laboratories, Inc. (IDXX) is set to release second-quarter 2024 results on Aug 6, before the opening bell. Q2 Estimates The Zacks Consensus Estimate for earnings is pinned at $2.87 per share, which implies a 7.5% rise from the year-ago reported figure. Estimates for IDEXX's second-quarter earnings have moved south by a marginal 0.3% to $2.87 per share in the past seven days. In the second quarter, IDXX's Companion Animal Group ("CAG") Diagnostics recurring revenues are expected to have maintained the ...